Labs, the leader in standards for AI-ready structured data, today announced a powerful new suite of AI-enhanced features that give data analysts a fast and governed way to explore data and deliver ...

FILSPARI holds strong market potential as the first FDA-approved non-immunosuppressive therapy for IgA nephropathy, a rare kidney disease with significant unmet needs. As more patients and providers ...

The firm touted new assays, provided an update on its nanopore sequencer, and offered insights into upcoming pipeline ...